AGER and diabetes mellitus: These findings provide a scientific basis for the further development of C-PC as a potential neuroprotective agent targeting AGE–RAGE–ER stress pathways in the context of diabetes-associated neurodegeneration and other RAGE-driven neurodegenerative disorders.